valine and pitavastatin

valine has been researched along with pitavastatin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Shiomi, M; Tsujioka, A; Tsujioka, H; Yoshida, K	1
Bae, KS; Jin, S; Jung, JA; Kim, MJ; Kim, YH; Lim, HS; Noh, YH	1
Galetin, A; Houston, JB; Kenworthy, KE; Ménochet, K	1
Owen, A; Riley, RJ; Soars, AC; Soars, MG; White, P; Williamson, B	1

Trials

1 trial(s) available for valine and pitavastatin

Article	Year
Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers. Clinical therapeutics, 2012, Volume: 34, Issue:4 Topics: Adult; Antihypertensive Agents; Cross-Over Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Quinolines; Reference Values; Republic of Korea; Tetrazoles; Valine; Valsartan	2012

Article

Year

Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers.

Clinical therapeutics, 2012, Volume: 34, Issue:4

Topics: Adult; Antihypertensive Agents; Cross-Over Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Quinolines; Reference Values; Republic of Korea; Tetrazoles; Valine; Valsartan

2012

Other Studies

3 other study(ies) available for valine and pitavastatin

Article	Year
Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:6 Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Biological Availability; Drug Therapy, Combination; Echocardiography; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Nitric Oxide; Quinolines; Rabbits; Reactive Oxygen Species; Tetrazoles; Tyrosine; Valine; Valsartan	2008
Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Transport; Bosentan; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Kinetics; Models, Biological; Organic Anion Transporters; Piperidines; Pravastatin; Pyrimidines; Quinolines; Rats; Rosuvastatin Calcium; Species Specificity; Sulfonamides; Telmisartan; Tetrazoles; Valine; Valsartan	2012
Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA. Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:10 Topics: Base Sequence; Cells, Cultured; Cytochrome P-450 CYP3A; Drug Interactions; Estrone; Female; Fluorobenzenes; Hepatocytes; Humans; Imidazoles; Liver-Specific Organic Anion Transporter 1; Male; Molecular Sequence Data; Organic Anion Transporters; Pyrimidines; Quinolines; RNA, Small Interfering; Rosuvastatin Calcium; Sulfonamides; Tetrazoles; Valine; Valsartan; Xenobiotics	2013